153 related articles for article (PubMed ID: 34500186)
1. Synthesis, in vitro cytotoxicity and biological evaluation of twenty novel 1,3-benzenedisulfonyl piperazines as antiplatelet agents.
Liu XJ; Wang Y; Wang X; Zhang ZH
Bioorg Med Chem; 2021 Sep; 46():116390. PubMed ID: 34500186
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and in vitro anti-platelet aggregation activities of 2-methoxy-5-arylamido-N-(pyridin-3-yl-methyl)benzamides.
Wang Y; Wang X; Chen X; Liu X
Arch Pharm (Weinheim); 2019 Jan; 352(1):e1800257. PubMed ID: 30500077
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and the Evaluations in vitro Antiplatelet Aggregation Activities of 4-Ethoxyisophthalamides.
Liu XJ; Shi TE; Wang X; Wei TT; Meng X
Cardiovasc Hematol Agents Med Chem; 2015; 13(2):124-8. PubMed ID: 26695422
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of 4-methoxy-3-arylamido-N-(substitutedphenyl)benzamide derivatives as potential antiplatelet agents.
Liu X; Chen X; Qiu K; Zhang Z
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900231. PubMed ID: 31808975
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and biological evaluation of N-arylpiperazine derivatives of 4,4-dimethylisoquinoline-1,3(2H,4H)-dione as potential antiplatelet agents.
Marcinkowska M; Kotańska M; Zagórska A; Śniecikowska J; Kubacka M; Siwek A; Bucki A; Pawłowski M; Bednarski M; Sapa J; Starek M; Dąbrowska M; Kołaczkowski M
J Enzyme Inhib Med Chem; 2018 Dec; 33(1):536-545. PubMed ID: 29482394
[TBL] [Abstract][Full Text] [Related]
6. [Design, synthesis of novel N, N'-bis-(halogenophenyl)-4- methoxybenzene-1, 3-disulfonamides and evaluation of their anti-platelet aggregation activity].
Li GA; Wang X; Meng X; Lin YB; Li X; Liu XJ
Yao Xue Xue Bao; 2015 Feb; 50(2):185-90. PubMed ID: 25975026
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological evaluation of some dibenzofuran-piperazine derivatives.
Yurttaş L; Abu Mohsen U; Ozkan Y; Cobanoglu S; Levent S; Kaplancikli ZA
J Enzyme Inhib Med Chem; 2016 Dec; 31(6):1177-83. PubMed ID: 26581445
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of N6-alkyl(aryl)-2-alkyl(aryl)thioadenosines as antiplatelet agents.
Liu G; Xu J; Chen N; Zhang S; Ding Z; Du H
Eur J Med Chem; 2012 Jul; 53():114-23. PubMed ID: 22531380
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of antiplatelet 2-aminochromones.
Morris J; Wishka DG; Lin AH; Humphrey WR; Wiltse AL; Gammill RB; Judge TM; Bisaha SN; Olds NL; Jacob CS
J Med Chem; 1993 Jul; 36(14):2026-32. PubMed ID: 8336341
[TBL] [Abstract][Full Text] [Related]
10. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
[TBL] [Abstract][Full Text] [Related]
11. Synthesis of 4-Methoxy-1, 3-Benzenediolylhydrazones and Evaluation of Their Anti-Platelet Aggregation Activity.
Wang C; Wang Y; Deng Q; Liu X
Iran J Pharm Res; 2019; 18(4):1803-1815. PubMed ID: 32184847
[TBL] [Abstract][Full Text] [Related]
12. Non-peptide-based new class of platelet aggregation inhibitors: Design, synthesis, bioevaluation, SAR, and in silico studies.
Jaiswal PK; Sharma V; Kumar S; Mathur M; Swami AK; Yadav DK; Chaudhary S
Arch Pharm (Weinheim); 2018 Apr; 351(3-4):e1700349. PubMed ID: 29522645
[TBL] [Abstract][Full Text] [Related]
13. N-substituted indole carbohydrazide derivatives: synthesis and evaluation of their antiplatelet aggregation activity.
Mirfazli SS; Kobarfard F; Firoozpour L; Asadipour A; Esfahanizadeh M; Tabib K; Shafiee A; Foroumadi A
Daru; 2014 Sep; 22(1):65. PubMed ID: 25238875
[TBL] [Abstract][Full Text] [Related]
14. Antiplatelet agents based on cyclooxygenase inhibition without ulcerogenesis. Evaluation and synthesis of 4,5-bis(4-methoxyphenyl)-2-substituted-thiazoles.
Tanaka A; Sakai H; Motoyama Y; Ishikawa T; Takasugi H
J Med Chem; 1994 Apr; 37(8):1189-99. PubMed ID: 8164261
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
16. Novel non-peptide GPIIb/IIIa antagonists: synthesis and biological activities of 2-[4-[2-(4-amidinobenzoylamino)-2-(substituted)acetyl]-3-(2-methoxy-2-oxoethyl)-2-oxopiperazinyl] acetic acids.
Kitamura S; Fukushi H; Miyawaki T; Kawamura M; Terashita Z; Sugihara H; Naka T
Chem Pharm Bull (Tokyo); 2001 Mar; 49(3):258-67. PubMed ID: 11253914
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of antiplatelet ortho-carbonyl hydroquinones with differential action on platelet aggregation stimulated by collagen or TRAP-6.
Méndez D; Urra FA; Millas-Vargas JP; Alarcón M; Rodríguez-Lavado J; Palomo I; Trostchansky A; Araya-Maturana R; Fuentes E
Eur J Med Chem; 2020 Apr; 192():112187. PubMed ID: 32155530
[TBL] [Abstract][Full Text] [Related]
18. Rational Design and Synthesis of 1-(Arylideneamino)-4-aryl-1H-imidazole-2-amine Derivatives as Antiplatelet Agents.
Amidi S; Esfahanizadeh M; Tabib K; Soleimani Z; Kobarfard F
ChemMedChem; 2017 Jun; 12(12):962-971. PubMed ID: 28494138
[TBL] [Abstract][Full Text] [Related]
19. Synthesis of novel indole hydrazone derivatives and evaluation of their antiplatelet aggregation activity.
Mashayekhi V; Haj Mohammad Ebrahim Tehrani K; Amidi S; Kobarfard F
Chem Pharm Bull (Tokyo); 2013; 61(2):144-50. PubMed ID: 23154304
[TBL] [Abstract][Full Text] [Related]
20. Stereoselective inhibition of human platelet aggregation by R-138727, the active metabolite of CS-747 (prasugrel, LY640315), a novel P2Y12 receptor inhibitor.
Hasegawa M; Sugidachi A; Ogawa T; Isobe T; Jakubowski JA; Asai F
Thromb Haemost; 2005 Sep; 94(3):593-8. PubMed ID: 16268477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
